GSK wins FDA nod for new shingles vaccine format (GSK:NYSE)
Magdalena Wygralak GSK (NYSE:GSK) announced Thursday that the U.S. Food and Drug Administration (FDA) approved a new prefilled syringe presentation of its shingles vaccine, Shingrix, offering a convenient administration option…
Share